EPM2A antibody (AA 1-331)

Catalog No. ABIN2261150

The Mouse Monoclonal anti-EPM2A antibody is suitable to detect EPM2A in samples from Human. It has been validated for WB.

Quick Overview for EPM2A antibody (AA 1-331) (ABIN2261150)

Target: EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This EPM2A antibody is un-conjugated

Application: Western Blotting (WB)

Clone: 9H116

Product Details anti-EPM2A Antibody

Binding Specificity: AA 1-331

Cross-Reactivity: Human

Cross-Reactivity (Details): Calculated cross reactivity: Hu

Characteristics: Epilepsy, Progressive Myoclonus Type 2A (Lafora Disease, EPM2A, Laforin, LD, LDE, EPM2, MELF, LAFPTPase, FLJ11207, KIAA0766)

Purification: Purified by Protein G immunoaffinity chromatography.

Immunogen: Purified, E. coli-derived full length recombinant human Laforin (rhLaforin, aa 1-331, UniProt # O95278).

Isotype: IgG2b

Application Details

Application Notes: Optimal working conditions should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Reconstitution: Reconstitute in PBS containing 0.02 % sodium azide.

Buffer: Supplied as lyophilized from a 0.2um sterile-filtered solution in PBS with 5 % trehalose.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: -20°C

Target Details for EPM2A

Target: EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))

Alternative Name: Epilepsy, Progressive Myoclonus Type 2A

UniProt: O95278

Pathways: Cellular Glucan Metabolic Process